These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22640805)

  • 1. Shared gene expression alterations in prostate cancer and histologically benign prostate from patients with prostate cancer.
    Kosari F; Cheville JC; Ida CM; Karnes RJ; Leontovich AA; Sebo TJ; Erdogan S; Rodriguez E; Murphy SJ; Vasmatzis G
    Am J Pathol; 2012 Jul; 181(1):34-42. PubMed ID: 22640805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal activation associated with development of prostate cancer in prostate-targeted fibroblast growth factor 8b transgenic mice.
    Elo TD; Valve EM; Seppänen JA; Vuorikoski HJ; Mäkelä SI; Poutanen M; Kujala PM; Härkönen PL
    Neoplasia; 2010 Nov; 12(11):915-27. PubMed ID: 21076617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection.
    Gregg JL; Brown KE; Mintz EM; Piontkivska H; Fraizer GC
    BMC Cancer; 2010 Apr; 10():165. PubMed ID: 20426842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-PCa-2: a novel transcript highly overexpressed in human prostate and prostate cancer.
    Weigle B; Kiessling A; Ebner R; Fuessel S; Temme A; Meye A; Schmitz M; Rieger MA; Ockert D; Wirth MP; Rieber EP
    Int J Cancer; 2004 May; 109(6):882-92. PubMed ID: 15027122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells.
    Grzmil M; Thelen P; Hemmerlein B; Schweyer S; Voigt S; Mury D; Burfeind P
    Am J Pathol; 2003 Aug; 163(2):543-52. PubMed ID: 12875974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches.
    Özdemir BC; Hensel J; Secondini C; Wetterwald A; Schwaninger R; Fleischmann A; Raffelsberger W; Poch O; Delorenzi M; Temanni R; Mills IG; van der Pluijm G; Thalmann GN; Cecchini MG
    PLoS One; 2014; 9(12):e114530. PubMed ID: 25485970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asporin is a stromally expressed marker associated with prostate cancer progression.
    Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
    Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteine-rich secretory protein-3 (CRISP3) is strongly up-regulated in prostate carcinomas with the TMPRSS2-ERG fusion gene.
    Ribeiro FR; Paulo P; Costa VL; Barros-Silva JD; Ramalho-Carvalho J; Jerónimo C; Henrique R; Lind GE; Skotheim RI; Lothe RA; Teixeira MR
    PLoS One; 2011; 6(7):e22317. PubMed ID: 21814574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Random forest-based modelling to detect biomarkers for prostate cancer progression.
    Toth R; Schiffmann H; Hube-Magg C; Büscheck F; Höflmayer D; Weidemann S; Lebok P; Fraune C; Minner S; Schlomm T; Sauter G; Plass C; Assenov Y; Simon R; Meiners J; Gerhäuser C
    Clin Epigenetics; 2019 Oct; 11(1):148. PubMed ID: 31640781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer.
    Tyekucheva S; Bowden M; Bango C; Giunchi F; Huang Y; Zhou C; Bondi A; Lis R; Van Hemelrijck M; Andrén O; Andersson SO; Watson RW; Pennington S; Finn SP; Martin NE; Stampfer MJ; Parmigiani G; Penney KL; Fiorentino M; Mucci LA; Loda M
    Nat Commun; 2017 Sep; 8(1):420. PubMed ID: 28871082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Panel of Biomarkers for Diagnosis of Prostate Cancer Using Urine Samples.
    Guo J; Yang J; Zhang X; Feng X; Zhang H; Chen L; Johnson H; Persson JL; Xiao K
    Anticancer Res; 2018 Mar; 38(3):1471-1477. PubMed ID: 29491074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer-associated gene expression alterations determined from needle biopsies.
    Qian DZ; Huang CY; O'Brien CA; Coleman IM; Garzotto M; True LD; Higano CS; Vessella R; Lange PH; Nelson PS; Beer TM
    Clin Cancer Res; 2009 May; 15(9):3135-42. PubMed ID: 19366833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of a panel of gene expression in prostate cancer--with emphasis on NPY expression analysis.
    Liu AJ; Furusato B; Ravindranath L; Chen YM; Srikantan V; McLeod DG; Petrovics G; Srivastava S
    J Zhejiang Univ Sci B; 2007 Dec; 8(12):853-9. PubMed ID: 18257117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
    Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
    Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia.
    Matos AR; Coutinho-Camillo CM; Thuler LC; Fonseca FP; Soares FA; Silva EA; Gimba ER
    Exp Mol Pathol; 2013 Jun; 94(3):438-44. PubMed ID: 23470460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of the annexin family protein family is associated with prostate cancer progression.
    Xin W; Rhodes DR; Ingold C; Chinnaiyan AM; Rubin MA
    Am J Pathol; 2003 Jan; 162(1):255-61. PubMed ID: 12507908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies.
    Alinezhad S; Väänänen RM; Mattsson J; Li Y; Tallgrén T; Tong Ochoa N; Bjartell A; Åkerfelt M; Taimen P; Boström PJ; Pettersson K; Nees M
    PLoS One; 2016; 11(5):e0155901. PubMed ID: 27196083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR2 expression correlates with prostate cancer progression.
    Lu Y; Cai Z; Xiao G; Liu Y; Keller ET; Yao Z; Zhang J
    J Cell Biochem; 2007 Jun; 101(3):676-85. PubMed ID: 17216598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative metabolic and transcriptomic profiling of prostate cancer tissue containing reactive stroma.
    Andersen MK; Rise K; Giskeødegård GF; Richardsen E; Bertilsson H; Størkersen Ø; Bathen TF; Rye M; Tessem MB
    Sci Rep; 2018 Sep; 8(1):14269. PubMed ID: 30250137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the platelet-derived growth factor receptor in prostate cancer and treatment implications with tyrosine kinase inhibitors.
    Hofer MD; Fecko A; Shen R; Setlur SR; Pienta KG; Tomlins SA; Chinnaiyan AM; Rubin MA
    Neoplasia; 2004; 6(5):503-12. PubMed ID: 15548358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.